LMAT Nasdaq· LeMaitre Vascular Inc.
FundamentalsNews digest Peer analysis
LMAT Nasdaq· LeMaitre Vascular Inc.
Earnings report Q3 2023

LeMaitre Vascular Reports Strong Revenue Growth in Latest Quarter

Segments of Revenue

LeMaitre Vascular, Inc. reported net sales of $47.41 million for the latest quarter, representing a significant increase from $39.03 million in the same period last year. The company's revenue growth was primarily driven by strong performance across its major geographic areas, including the Americas, Europe, and Asia.


LeMaitre Vascular demonstrated robust revenue growth in the latest quarter, outperforming the previous year's results. The company's ability to increase net sales by approximately $8.38 million can be attributed to its effective sales and marketing strategies, as well as its focus on expanding its presence in key markets. Management highlighted the positive impact of their efforts to strengthen customer relationships and enhance product offerings, which contributed to the overall revenue growth.


While LeMaitre Vascular achieved impressive revenue growth, it also faced certain challenges in the latest quarter. The company experienced an increase in operating expenses, with total expenses amounting to $21.64 million, compared to $18.92 million in the same period last year. This rise in expenses can be attributed to higher sales and marketing costs, general and administrative expenses, and research and development expenditures. The company also incurred restructuring costs, which further impacted its financial performance.


LeMaitre Vascular's comprehensive income for the latest quarter stood at $6.62 million, a significant improvement from $3.77 million in the previous year. The company's ability to generate higher comprehensive income can be attributed to its strong revenue growth and effective cost management strategies. Additionally, LeMaitre Vascular experienced a decrease in other comprehensive loss, primarily driven by a reduction in foreign currency translation adjustment and unrealized losses on short-term marketable securities.


LeMaitre Vascular delivered a strong performance in the latest quarter, with notable revenue growth and improved comprehensive income. The company's focus on expanding its market presence and enhancing customer relationships has proven successful, resulting in increased net sales. However, LeMaitre Vascular also faced challenges, including higher operating expenses and restructuring costs. Overall, the company's ability to drive revenue growth and effectively manage costs positions it well for future success in the vascular medical device industry.

Source documents

Form 10-Q  filed on Nov 07, 2023
54 pages scanned

Reference data

Company financials Q3 revenue 48.9M
Analyst estimates Q3 EPS beat by 25.97%
Sign up to Fey

Get in-depth analysis on thousands of stocks for just $30/month. Cancel anytime.